SCHEMBL23508486

SCHEMBL23508486

Fc1cc(F)cc(-c2nnc(CNc3nc(N4CCOCC4)nc4c(C(F)(F)F)cnn34)[nH]2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK1E P49674 10/20 0.38
▸ CSNK1D P48730 8/20 0.38
▸ MTOR P42345 2/20 0.36
▸ PTK2 Q05397 1/20 0.35
▸ PIK3R1 P27986 5/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ PIK3CA P42336 3/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3C2B O00750 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ PRKDC P78527 1/20 0.34
▸ RICTOR Q6R327 1/20 0.34
▸ RPTOR Q8N122 1/20 0.34
▸ PIK3C3 Q8NEB9 1/20 0.34
▸ MAPKAP1 Q9BPZ7 1/20 0.34
▸ MLST8 Q9BVC4 1/20 0.34
▸ PI4KB Q9UBF8 1/20 0.34
▸ USP2 O75604 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23497407 0.92 CSNK1D (0.44) CSNK1ECSNK1DMTORPIK3CAATM
SCHEMBL23497525 0.89 CSNK1D (0.40) CSNK1ECSNK1DMTORPIK3R1PIK3CA
SCHEMBL30590445 0.88 PIK3CA (0.40) CSNK1ECSNK1DMTORPIK3R1PIK3CA
SCHEMBL23497445 0.88 CSNK1E (0.40) CSNK1ECSNK1DCYP1A2USP2ALDH1A1
SCHEMBL30590497 0.86 CSNK1E (0.37) CSNK1ECSNK1DMTORPIK3R1CYP1A2
SCHEMBL25307846 0.86 CSNK1E (0.37) CSNK1ECSNK1DMTORPIK3R1CYP1A2
SCHEMBL25305733 0.85 SCN9A (0.38) CSNK1ECSNK1DPRKDCTDP1
SCHEMBL25300076 0.85 CSNK1E (0.37) CSNK1ECSNK1DMTORPIK3R1PIK3CB
SCHEMBL25263677 0.83 CSNK1E (0.36) CSNK1ECSNK1DMTORPIK3R1PIK3CA
SCHEMBL25256993 0.83 PIK3CA (0.37) CSNK1ECSNK1DMTORPTK2PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230117034-A1 PYRAZOLOTRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-20 — — US claimed
EP-4073072-A1 PYRAZOLOTRIAZINES Bayer Aktiengesellschaft (DE) 2022-10-19 — — EP claimed
US-20230117034-A1 PYRAZOLOTRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-20 — — US disclosed
US-20230117034-A1 PYRAZOLOTRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 2023-04-20 — — US disclosed
EP-4073072-A1 PYRAZOLOTRIAZINES Bayer Aktiengesellschaft (DE) 2022-10-19 — — EP disclosed
WO-2021116178-A1 PYRAZOLOTRIAZINES BAYER AKTIENGESELLSCHAFT (DE) 2021-06-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230117034-A1 PYRAZOLOTRIAZINES BRCA1, TPX2, CCND2 CSNK1E 1596/4885CSNK1D 963/4885MTOR 2669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback